N-myc gene amplification in rhabdomyosarcoma detected by fluorescence in situ hybridization: Its correlation with histologic features

Modern Pathology

Volumn 11, Issue 12, 1998, Pages 1222-1227

  Hachitanda, Yoichi ^a,b   Toyoshima, Satoshi ^b   Akazawa, Kouhei ^a   Tsuneyoshi, Masazumi ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b KITAKYUSHU MUNICIPAL MEDICAL CENTER   (Japan)

Author keywords

Amplification; Fluorescence in situ hybridization; N myc; Oncogene; Rhabdomyosarcoma

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CANCER SURVIVAL; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION FUNCTION; EMBRYONAL RHABDOMYOSARCOMA; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE AMPLIFICATION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; INFANT; MALE; ONCOGENE C MYB; PRIORITY JOURNAL; RHABDOMYOSARCOMA; TUMOR CELL;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; FEMALE; GENE AMPLIFICATION; GENES, MYC; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; INFANT; MALE; RETROSPECTIVE STUDIES; RHABDOMYOSARCOMA, ALVEOLAR; RHABDOMYOSARCOMA, EMBRYONAL; SURVIVAL RATE;

EID: 0032417124     PISSN: 08933952     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Newton WA, Gehan EA, Webber BL, Marsden HB, van Unnik AJ, Hamoudi AB, et al. Classification of rhabdomyosarcomas and related sarcomas: pathologic aspects and proposal for a new classification: an Intergroup Rhabdomyosarcoma Study. Cancer 1995:;76:1073-85.
2. Wijnaenbdts LC, van der Linden JC, van Unnik AJ, Delemarre JF, Voute PA, Meijer CJ. Histopathological classification of childhood rhabdomyosarcomas: relationship with clinical parameters and prognosis. Hum Pathol 1994;25:900-7.
3. Schwab M, Alitalo K, Klempnauer BCH, Varmus HE, Bishop JM, Gilbert F, et al. Amplified DNA with limited homology to myc cellular oncogene is shared by human neuroblastoma cell lines and a neuroblastoma tumor. Nature 1983;305:245-8.
4. Brodeur GM, Seeger RC, Schwab M, Varmus HE, Bishop JM. Amplification of N-mycin untreated humanneuroblastomas correlates with advanced disease stage. Science 1984;224: 1121-4.
5. Seeger RC, Brodeur GM, Sather H, Dalton A, Siegel SE, Wong KY, et al. Association of multiple copies of the N-myc oncogene with rapid progression of neuroblastomas. N Engl J Med 1985;313:1111-6.
6. Dias P, Kumar P, Marsden HB, Gattamaneni HR, Heighway J, Kumar S. N-myc gene is amplified in alveolar rhabdomyosarcomas (RMS) but not in embryonal RMS. Int J Cancer 1990;45:593-6.
7. Driman D, Thorner PS, Greenberg ML, Chilon-MacNeill S, Squire J. MYCN gene amplification in rhabdomyosarcoma. Cancer 1994;73:2231-7.
8. Noguchi S, Tamiya S, Nagoshi M, Suita S, Fukuda T, Tsuneyoshi M. Nuclear morphometry and the MIB-1 index in rhabdomyosarcoma. Mod Pathol 1996;9:253-60.
9. Weiss SW, editor. Histological typing of soft tissue tumors. 2nd ed. Geneva: Springer-Velag; 1994.
10. Tsokos M, Webber BL, Parham DM, Wesley RA, Miser IS, Etcubanas E, et al. Rhabdomyosarcoma: a new classification scheme related to prognosis. Arch Pathol Lab Med 1992;116: 847-55.
11. Hachitanda Y, Saito M, Mori T, Hamazaki M. Application of fluorescence in situ hybridization to detect N-myc (MYCN) gene amplification on paraffin-embedded tissue sections of neuroblastomas. Med Pediatr Oncol 1997;29:135-8.
12. Shapiro DN, Valentine MB, Rowe ST, Sinclair AE, Sublett IE, Roberts WM, et al. Detection of N-myc gene amplification by fluorescence in situ hybridization: diagnostic utility for neuroblastoma. Am J Pathol 1993;142:1339-46.
13. Taylor CPF, McGuckin AG, Bown NP, Reid MM, Malcolm AJ, Pearson ADJ, et al. Rapid detection of prognostic genetic factors in neuroblastoma using fluorescence in situ hybridization on tumour imprints and bone marrow smears. Br J Cancer 1994;69:445-451.
14. Garson JA, Clayton J, McIntyre P, Kempshead JT. N-myc oncogene amplification in rhabdomyosarcoma at relapse. Lancet 1986;1:1496.
15. Mitani K, Kurosawa H, Suzuki A, Hayashi Y, Hanada R, Yamamoto K, et al. Amplification of N-myc in a rhabdomyosarcoma [Japanese]. Jpn J Cancer Res 1986;77:1062-5.
16. Inaba T, Nakashima M, Hanada R, Hayashi Y, Yamamoto K, Kamatsu A et al. Aggressive rhabdomyosarcoma in an elder child with amplification of N-myc [Japanese]. Jpn J Pediatr 1988;92:1805-8.
17. Anzai K, Akatuka J. N-myc oncogene amplification in a case of older children of rhabdomyosarcoma [Japanese]. Jpn J Pediatr Surg 1994;26:89-93.
18. Kelly KM, Womer RB, Sorensen PHB, Xiong QB, Barr FG. Common and variant gene fusions predict distinct clinical phenotypes in rhabdomyosarcoma. J Clin Oncol 1997;15: 1831-6.